Henk Derksen
Analyst · Rosenblatt Securities. Please go ahead
Thank you, Sagar. Fiscal Q1 2023 was a challenging quarter for Viavi. After record results in 2022, we saw an unanticipated deceleration in demand in the last three weeks of the quarter, concentrated among service providers. Fiscal Q1 revenue came in at $310.2 million down 5.1% year-over-year and below our guidance range of $317 million to $331 million. Viavi's operating profit margin at 21.7% improved 40 basis points from last quarter, although down 100 basis points of last year and came in within our guidance range of 20.7% to 22.1%. EPS at $0.23 was down 4.2% from both prior-year and prior quarter results but within a guidance range of $0.22 to $0.24. The current share count of 230.4 million shares includes dilutive impact of the remaining convertible notes of approximately 1.4 million shares. Now moving to our reported Q1 results by business segment, starting with NSE, NSE quarterly revenue at $218.9 million declined 3.9% year-over-year and was below our guidance range of $231 million to $241 million. As discussed earlier, our missed revenue guidance was a result of weakness in service providers segment late in the quarter. Within NSE, NE revenue of $194.9 million decreased 4.9% from a year-ago. Field instruments was down 9% year-over-year. Lab instruments across both wireless and optical combined was roughly flat. SE revenue at $24 million increased 4.3% year-over-year. NSE gross profit margin at 64.7% was flat year-over-year. Within NSE, NE gross profit margin at 64.4% decreased 40 basis points from last year, primarily due to declines in volume. SE gross profit margin at 66.7% increased 280 basis points year-over-year because of favorable product mix. NSE operating profit margin at 13.2% was below the guide range of 14% to 15% and decreased 30 basis points from a year-ago, reflecting the lower volumes partially offset by expense control. Now turning to OSP, first quarter revenue at $91.3 million was down 7.7% year-over-year. Coming off prior year record levels, revenue exceeded our guidance range of $86 million to $90 million. Gross profit margin at 56.7%. This is 100 basis points year-over-year and includes the impact of startup costs in our new Arizona facility. Operating profit margin of 42.3% exceeded the high end of our guide range of 39% to 41%. But it was a decrease of 180 basis points from a year ago. Now turning to the balance sheet, the ending balance of our total cash and short term investments was $517.1 million, down $47.8 million sequentially, primarily due to acquisitions, translations, and share repurchases to offset the dilution of our employee equity plan. Operating cash flow for the quarter was $26.6 million, a decrease of $26.8 million compared to $53.4 million in the year-ago period. The reduction was a result of timing of payroll and non-occurring income tax related payments. In addition, we invested $14.8 million in capital expenditures during the quarter compared to $15.7 million the prior-year, primarily to build out our new Arizona production facility. During fiscal Q1, we repurchased 1.3 million shares of our common stock for $18.7 million, thereby completing transactions under the 2019 repurchase plan that expired at the end of the quarter. As you may recall, in September, we announced that the board authorized a new common stock repurchase program for up to $300 million worth of our shares. This new plan allows us to be opportunistic as we think of our capital deployment strategy. Now on to our guidance, in view of the sudden and unexpected reduction in demand at the end of fiscal Q1 and continuing into October, we are reducing our outlook. We expect the fiscal second quarter 2022 revenue to be approximately $271 million plus or minus $10 million. Operating profit margin is expected to be 14.4% plus or minus 50 basis points and EPS to be in the range of $0.10 to $0.12. We expect NSE revenue to be approximately $195 million plus or minus $8 million with operating profit margin of 6% plus or minus 50 basis points. OSP revenue is expected to be approximately $76 million plus or minus $2 million with operating profit margin at 36% plus or minus 100 basis points. Our tax rate is expected to be between 24% to 26%. As a result of jurisdictional mix, we expect other income expenses to reflect a net expense of approximately $6 million. Share count is approximately 230.4 million shares based upon current stock price levels and includes the dilutive impact of approximately 1.4 million shares of the remaining convertible notes. With that, I will turn the call over to Oleg